GO:1904798 positive regulation of core promoter binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904798 describes any process that activates or increases the frequency, rate or extent of core promoter binding, a key step in transcriptional control.
• Core promoter binding is positively regulated by sequence-specific transcription factors that recruit coactivators and general transcription factors to DNA.
• Systematic interrogation of human promoters shows that core promoter elements and their flanking sequences determine the strength and regulation of transcription initiation.
• Convergent promoters can drive gene regulation through shared core promoter binding events, expanding the regulatory repertoire of the genome.
• Dysregulation of positive regulation of core promoter binding contributes to cancer, viral pathogenesis, and metabolic disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes that positively regulate core promoter binding.
Description
Positive regulation of core promoter binding (GO:1904798) is a biological process that increases the frequency, rate, or extent of core promoter binding, the physical association of transcription machinery with the core promoter region of a gene. Core promoters are DNA sequences that position RNA polymerase II and general transcription factors for accurate transcription initiation, and their binding is a prerequisite for gene expression. This GO term captures the regulatory events that enhance this binding, including the action of sequence-specific transcription factors, coactivators, and chromatin-modifying complexes that make core promoters more accessible. Understanding GO:1904798 is essential because the positive regulation of core promoter binding determines when and how strongly genes are expressed, influencing cell fate, development, and disease. Researchers studying transcriptional control, viral gene expression, and cancer biology rely on this term to annotate and interpret experimental data.
positive regulation of core promoter binding At A Glance
| GO ID | GO:1904798 |
|---|---|
| GO term | positive regulation of core promoter binding |
| Ontology | biological_process |
| Synonym | activation of core promoter binding; up regulation of core promoter binding; up-regulation of core promoter binding; upregulation of core promoter binding |
| Major function | Increases the frequency, rate or extent of core promoter binding, thereby enhancing transcription initiation |
| Related process | Regulation of transcription initiation by RNA polymerase II |
| Key regulators | Sequence-specific transcription factors, coactivators, and chromatin remodelers |
| Experimental evidence | Promoter reporter assays, ChIP, and systematic promoter interrogation |
What Is GO:1904798?
In simple terms, GO:1904798 describes any cellular process that boosts the binding of proteins to the core promoter, the central DNA region where transcription starts. According to the QuickGO definition, it is any process that activates or increases the frequency, rate or extent of core promoter binding. This includes the recruitment of transcription factors and coactivators that stabilize the preinitiation complex, as well as chromatin changes that expose core promoter elements.
Why Is positive regulation of core promoter binding Important in Cell Biology?
Positive regulation of core promoter binding is a central node in gene regulation because it directly controls the assembly of the transcription preinitiation complex and thus the output of gene expression programs. Dysregulation of this process can lead to inappropriate activation of oncogenes, silencing of tumor suppressors, or altered viral replication, making it a critical area for understanding disease mechanisms and developing targeted therapies.
• Controls the rate of transcription initiation for thousands of genes.
• Integrates signals from enhancers and sequence-specific transcription factors.
• Plays a role in viral gene expression, including hepatitis B virus pregenomic RNA.
• Contributes to cancer through aberrant activation of oncogenic promoters.
• Influences metabolic gene regulation, such as the LPD1 gene in yeast.
• Affects hematopoietic differentiation via regulation of cytokine promoters.
• Provides a mechanism for erythroid-specific gene expression.
• Is a target for experimental perturbation using CRISPR-based models.
• Helps explain how convergent promoters fine-tune gene regulation.
• Serves as a biomarker for transcriptional addiction in disease.
What Happens During positive regulation of core promoter binding?
Recruitment of sequence-specific transcription factors
In simple terms: First, activator proteins bind to nearby DNA elements and then help the core promoter bind its machinery.
Positive regulation of core promoter binding often begins when sequence-specific transcription factors recognize enhancer or promoter-proximal elements and recruit coactivators to the core promoter. For example, E2F positively regulates the NOX4 promoter in vascular smooth muscle cells, increasing core promoter occupancy. Similarly, AML1-related transcription factor PEBP2 positively regulates the GM-CSF promoter.
Assembly and stabilization of the preinitiation complex
In simple terms: Next, general transcription factors and RNA polymerase II assemble on the core promoter, and activators make this assembly more stable.
Once recruited, coactivators such as Mediator and chromatin-modifying enzymes facilitate the binding of TFIID, TFIIB, and RNA polymerase II to the core promoter. Systematic interrogation of human promoters revealed that core promoter elements and their context determine the efficiency of this assembly. Positive regulation increases the frequency or rate of this binding event.
Chromatin remodeling and accessibility
In simple terms: The DNA must be made accessible, so chromatin remodelers open up the core promoter region.
Positive regulation of core promoter binding frequently involves ATP-dependent chromatin remodelers and histone-modifying enzymes that create nucleosome-free regions at core promoters. This accessibility is essential for stable binding of the transcription machinery and is a key step in gene activation.
Convergent promoters and alternative regulation
In simple terms: Some genes have two promoters that face each other, and their binding can be positively regulated in a coordinated way.
Convergent promoters can share core promoter elements and exhibit positive regulation of core promoter binding that affects both transcription units. This architecture adds another layer of complexity to gene regulation and can be studied using promoter interrogation methods.
Key Genes Involved in GO:1904798 positive regulation of core promoter binding
The following genes and proteins are experimentally implicated in the positive regulation of core promoter binding, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PUF60 | Transcriptional and post-transcriptional regulation of HBV pregenomic RNA | Involved in positive regulation of core promoter binding for viral RNA expression |
| E2F | Activates the NOX4 promoter in vascular smooth muscle cells | Model for positive regulation of core promoter binding in oxidative stress |
| PEBP2 (AML1-related) | Positive and negative regulation of GM-CSF promoter | Demonstrates dual regulation of core promoter binding in hematopoiesis |
| HAP2/HAP3/HAP4 | Activation system for LPD1 gene in Saccharomyces cerevisiae | Classic example of positive regulation of core promoter binding in yeast |
| MGP promoter repressors | Downstream repressors of MGP promoter | Provides insight into negative and positive regulation of core promoter binding |
| Erythroid regulatory elements | Erythroid-specific gene expression | Early evidence for positive regulation of core promoter binding in differentiation |
| TFIID | Core promoter recognition | General transcription factor involved in core promoter binding |
| TFIIB | Preinitiation complex assembly | Required for core promoter binding and transcription initiation |
| RNA polymerase II | Transcription initiation | Central enzyme whose binding is positively regulated |
| Mediator complex | Coactivator recruitment | Bridges activators and core promoter machinery |
| Chromatin remodelers | Nucleosome displacement | Facilitate access to core promoters |
| Convergent promoter factors | Shared core promoter regulation | Example of coordinated positive regulation |
| NOX4 | Target gene of E2F | Readout for positive regulation of core promoter binding |
| GM-CSF | Target gene of PEBP2 | Cytokine promoter regulation model |
| LPD1 | Target gene of HAP2/3/4 | Yeast metabolic gene regulation model |
| HBV pregenomic RNA | Viral transcript regulated by PUF60 | Viral pathogenesis model |
| MGP | Matrix Gla protein | Promoter regulation in vascular biology |
How Is positive regulation of core promoter binding Regulated?
Positive regulation of core promoter binding is itself regulated by upstream signaling pathways and transcription factor availability. For instance, E2F activity is cell-cycle dependent and its ability to positively regulate the NOX4 promoter is modulated by growth signals. In yeast, the HAP2/HAP3/HAP4 system responds to carbon source availability to regulate LPD1 core promoter binding. Additionally, viral proteins such as PUF60 can hijack this process to enhance HBV pregenomic RNA expression. Chromatin accessibility and coactivator recruitment further tune the extent of positive regulation.
positive regulation of core promoter binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| E2F | Cancer, oxidative stress | Knockout of E2F in vascular smooth muscle cells followed by NOX4 promoter reporter assay |
| PUF60 | Hepatitis B virus infection | Knockdown or knockout of PUF60 in HBV-infected hepatocytes |
| PEBP2 (AML1) | Leukemia, hematopoietic disorders | Point mutation of PEBP2 DNA-binding domain in myeloid cell lines |
| HAP2/HAP3/HAP4 | Metabolic regulation (yeast model) | Knockout of HAP2 in Saccharomyces cerevisiae and LPD1 promoter activity assay |
| MGP | Vascular calcification | Overexpression of MGP promoter repressors in vascular cells |
Cancer
Aberrant positive regulation of core promoter binding can drive oncogene expression. E2F-mediated activation of the NOX4 promoter in vascular smooth muscle cells links this process to oxidative stress and proliferative signaling. Dysregulated transcription factor activity at core promoters is a hallmark of many cancers, making this process a potential therapeutic target.
Viral pathogenesis
Hepatitis B virus exploits positive regulation of core promoter binding to express its pregenomic RNA. PUF60 is involved in both transcriptional and post-transcriptional regulation of HBV pregenomic RNA, highlighting how viruses co-opt host core promoter machinery.
Hematological and metabolic disorders
Positive regulation of core promoter binding controls cytokine genes such as GM-CSF through PEBP2, affecting hematopoietic differentiation. In yeast, the HAP2/HAP3/HAP4 system regulates LPD1, a metabolic gene, illustrating conserved mechanisms that may inform human metabolic disease research.
From positive regulation of core promoter binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate core promoter binding? | CRISPR knockout of gene X followed by core promoter reporter assay |
| Which domain of transcription factor Y is required for positive regulation? | Point mutation knock-in of specific residues in gene Y |
| Does a disease-associated variant alter core promoter binding? | Knock-in of the variant allele and ChIP for core promoter factors |
| Where does protein Z bind at the core promoter? | Tagged knock-in of Z with ChIP-seq or CUT&RUN |
| Does overexpression of coactivator A enhance transcription? | Overexpression of A and measurement of core promoter occupancy |
| Can convergent promoters be differentially regulated? | Knockout of one promoter and assessment of the other |
How to Study the positive regulation of core promoter binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Luciferase reporter assay | Core promoter activity | Testing positive regulation by a transcription factor |
| ChIP-qPCR | Occupancy of core promoter by transcription machinery | Measuring core promoter binding in vivo |
| MPRA | Enhancer/promoter regulatory activity | Systematic interrogation of human promoters |
| CRISPR knockout | Loss-of-function effect on core promoter binding | Identifying positive regulators |
| Point mutation knock-in | Effect of specific residues on regulation | Dissecting DNA-binding domains |
| Overexpression | Gain-of-function effect on core promoter binding | Testing coactivator sufficiency |
| RNA-seq | Global transcriptional changes | Downstream consequences of altered core promoter binding |
| ATAC-seq | Chromatin accessibility at core promoters | Assessing chromatin remodeling |
Promoter reporter assays
Luciferase or fluorescent reporters driven by core promoter sequences are used to measure positive regulation of core promoter binding. This method quantifies the frequency or rate of transcription initiation in response to activators.
Chromatin immunoprecipitation (ChIP)
ChIP with antibodies against general transcription factors or RNA polymerase II measures the occupancy of core promoters. It is a direct readout of core promoter binding and its positive regulation.
Systematic promoter interrogation
Massively parallel reporter assays (MPRA) and related techniques systematically interrogate thousands of human promoters to identify sequences that positively regulate core promoter binding.
CRISPR-based perturbation
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes hypothesized to positively regulate core promoter binding.
How CRISPR Can Be Used to Study GO:1904798 positive regulation of core promoter binding
Knockout
CRISPR knockout of candidate genes is used to test whether they are required for positive regulation of core promoter binding. For example, knocking out E2F reduces NOX4 promoter activity, and knocking out PUF60 affects HBV pregenomic RNA expression.
Point Mutation
Point mutation knock-in allows precise dissection of residues critical for positive regulation. Mutating the DNA-binding domain of PEBP2 alters GM-CSF promoter regulation, and similar approaches can be applied to other transcription factors.
Knock-in
Knock-in of tagged versions of transcription factors or coactivators enables ChIP-seq and imaging to map core promoter binding sites. This is valuable for studying factors like TFIID and RNA polymerase II.
Overexpression
Overexpression of activators or coactivators can enhance core promoter binding and drive transcription. This approach is used to test sufficiency of positive regulators such as E2F and HAP2/HAP3/HAP4.
How EDITGENE Supports positive regulation of core promoter binding Research
Researchers studying positive regulation of core promoter binding-related genes often need to determine whether a candidate gene is causally involved in transcriptional activation, and CRISPR-based models provide the most direct way to establish causality. EDITGENE offers a comprehensive suite of services to support these investigations.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of core promoter binding research.
Frequently Asked Questions About positive regulation of core promoter binding
What is GO:1904798 positive regulation of core promoter binding?
GO:1904798 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of core promoter binding.
What genes are involved in positive regulation of core promoter binding?
Genes such as PUF60, E2F, PEBP2, and HAP2/HAP3/HAP4 have been experimentally implicated in this process.
How is positive regulation of core promoter binding measured?
It is measured using promoter reporter assays, ChIP for core promoter factors, and systematic promoter interrogation methods.
What diseases are associated with dysregulated core promoter binding?
Cancer, viral hepatitis, and hematopoietic disorders have been linked to altered positive regulation of core promoter binding.
What is the role of E2F in core promoter binding?
E2F positively regulates the NOX4 promoter in vascular smooth muscle cells, increasing core promoter binding.
How does PUF60 regulate HBV pregenomic RNA?
PUF60 is involved in transcriptional and post-transcriptional regulation of HBV pregenomic RNA, affecting core promoter binding.
Can CRISPR be used to study positive regulation of core promoter binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to dissect causal roles of genes in this process.
What are convergent promoters and how do they relate to core promoter binding?
Convergent promoters are overlapping promoters that can share core promoter elements and exhibit coordinated positive regulation.
What is the HAP2/HAP3/HAP4 system?
It is a yeast activation system that positively regulates the LPD1 gene by increasing core promoter binding.
How does PEBP2 regulate the GM-CSF promoter?
PEBP2 (AML1-related) positively and negatively regulates GM-CSF promoter activity, demonstrating dual control of core promoter binding.
Conclusion
Positive regulation of core promoter binding (GO:1904798) is a fundamental biological process that governs transcription initiation by enhancing the recruitment and stabilization of the transcription machinery at core promoters. Its dysregulation is implicated in cancer, viral pathogenesis, and metabolic disorders, making it a key area of biomedical research. Advances in CRISPR-based models and high-throughput promoter assays continue to uncover new regulators and mechanisms, offering opportunities for therapeutic intervention.
References
- 1. Sun S et al.. 2017. Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression.. Sci Rep 7(1):12874 PMID: 28993636
- 2. Wiechens E et al.. 2025. Gene regulation by convergent promoters.. Nat Genet 57(1):206-217 PMID: 39779959
- 3. Caiado H et al.. 2024. Transcriptional Regulation of the Human MGP Promoter: Identification of Downstream Repressors.. Int J Mol Sci 25(23) PMID: 39684309
- 4. Weingarten-Gabbay S et al.. 2019. Systematic interrogation of human promoters.. Genome Res 29(2):171-183 PMID: 30622120
- 5. Zhang L et al.. 2008. Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F.. Free Radic Biol Med 45(5):679-85 PMID: 18554521
- 6. Raich N et al.. 1993. Erythroid regulatory elements.. Stem Cells 11(2):95-104 PMID: 8096156
- 7. Takahashi A et al.. 1995. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2.. Blood 86(2):607-16 PMID: 7605990
- 8. Bowman SB et al.. 1992. Positive regulation of the LPD1 gene of Saccharomyces cerevisiae by the HAP2/HAP3/HAP4 activation system.. Mol Gen Genet 231(2):296-303 PMID: 1310523
